Effects of AF3442 [N-(9-ethyl-9H-carbazol-3-yl)-2-(trifluoromethyl)benzamide], a novel inhibitor of human microsomal prostaglandin E synthase-1, on prostanoid biosynthesis in human monocytes in vitro
Annalisa Bruno(University of Chieti-Pescara), Paola Patrignani(University of Chieti-Pescara), Giorgina Mangano(Angelini Pharma (Italy)), Emanuela Ricciotti(Translational Therapeutics (United States)), Maria Alessandra Alisi(Angelini Pharma (Italy)), Isabella Coletta(Angelini Pharma (Italy)), Claudio Milanese(Angelini Pharma (Italy)), Melania Dovizio(Queen's University), Stefania Tacconelli(University of Chieti-Pescara), Lorenzo Polenzani(Angelini Pharma (Italy)), Marta L. Capone(University of Chieti-Pescara), Andrea Di Francesco(Emcore (United States)), Luigia Di Francesco(Queen's University), Paola Anzellotti(University of Chieti-Pescara)
Cited by 51
Related Papers
Prostaglandins and Inflammation
|Arteriosclerosis Thrombosis and Vascular Biology|2011|3.7k
Selective Cumulative Inhibition of Platelet Thromboxane Production by Low-dose Aspirin in Healthy Subjects
|Journal of Clinical Investigation|1982|939
A time to fast
|Science|2018|516
Nicotinamide Improves Aspects of Healthspan, but Not Lifespan, in Mice
|Cell Metabolism|2018|332
Restoration of energy homeostasis by SIRT6 extends healthy lifespan
|Nature Communications|2021|196